JP2006507484A5 - - Google Patents

Download PDF

Info

Publication number
JP2006507484A5
JP2006507484A5 JP2004539916A JP2004539916A JP2006507484A5 JP 2006507484 A5 JP2006507484 A5 JP 2006507484A5 JP 2004539916 A JP2004539916 A JP 2004539916A JP 2004539916 A JP2004539916 A JP 2004539916A JP 2006507484 A5 JP2006507484 A5 JP 2006507484A5
Authority
JP
Japan
Prior art keywords
yyx
ysa
motif
peptide
tandem repeat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004539916A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006507484A (ja
JP4533750B2 (ja
Filing date
Publication date
Priority claimed from US10/256,538 external-priority patent/US20040072236A1/en
Application filed filed Critical
Publication of JP2006507484A publication Critical patent/JP2006507484A/ja
Publication of JP2006507484A5 publication Critical patent/JP2006507484A5/ja
Application granted granted Critical
Publication of JP4533750B2 publication Critical patent/JP4533750B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004539916A 2002-09-27 2003-09-26 ＰｒＰＳｃ相互作用分子とその用途 Expired - Fee Related JP4533750B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/256,538 US20040072236A1 (en) 2002-09-27 2002-09-27 PrPSc -interacting molecules and uses thereof
PCT/US2003/030273 WO2004029072A2 (en) 2002-09-27 2003-09-25 PrPsc -INTERACTING MOLECULES AND USES THEREOF

Publications (3)

Publication Number Publication Date
JP2006507484A JP2006507484A (ja) 2006-03-02
JP2006507484A5 true JP2006507484A5 (enExample) 2006-11-02
JP4533750B2 JP4533750B2 (ja) 2010-09-01

Family

ID=32041771

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004539916A Expired - Fee Related JP4533750B2 (ja) 2002-09-27 2003-09-26 ＰｒＰＳｃ相互作用分子とその用途

Country Status (7)

Country Link
US (2) US20040072236A1 (enExample)
EP (1) EP1575989B1 (enExample)
JP (1) JP4533750B2 (enExample)
AT (1) ATE467124T1 (enExample)
CA (1) CA2500120A1 (enExample)
DE (1) DE60332488D1 (enExample)
WO (1) WO2004029072A2 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041807B1 (en) 1999-06-23 2006-05-09 Caprion Pharmaceuticals, Inc. Antibodies to a YYX epitope of a mammalian prion protein
JP4235544B2 (ja) 2001-05-31 2009-03-11 アドライフ インコーポレーティッド 欠陥折畳み蛋白質センサー方法
US20050026165A1 (en) * 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
US20040072236A1 (en) 2002-09-27 2004-04-15 Neil Cashman PrPSc -interacting molecules and uses thereof
CA2522483A1 (en) * 2003-04-14 2004-10-28 Julia T. Lathrop Method for identifying ligands specific for structural isoforms of proteins
US7439041B2 (en) 2003-08-13 2008-10-21 Novartis Vaccines And Diagnostics, Inc. Prion-specific peptide reagents
US20060035242A1 (en) * 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
US20060057671A1 (en) * 2004-09-10 2006-03-16 Orser Cindy S Immobilized probes and methods of detecting conformationally altered prion proteins
US7328063B2 (en) * 2004-11-30 2008-02-05 Cardiac Pacemakers, Inc. Method and apparatus for arrhythmia classification using atrial signal mapping
WO2006076683A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Isolation and detection of pathogenic prions
JP5162250B2 (ja) * 2005-01-13 2013-03-13 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド プリオン特異的ペプチド試薬を使用するｅｌｉｓａアッセイ
MX2007009819A (es) * 2005-02-15 2007-11-07 Adlyfe Inc Metodo para detectar proteinas y priones desplegados.
EP1931695B1 (en) * 2005-09-09 2013-04-10 Novartis AG Prion-specific peptoid reagents
JP4769925B2 (ja) * 2006-03-15 2011-09-07 国立大学法人東北大学 異常型プリオン蛋白質の濃縮方法、および除去方法
US7601506B2 (en) * 2006-07-28 2009-10-13 Idexx Laboratories, Inc. Identification of leucocytes bearing diagnostic markers for transmissible spongiform encephalopathies
BRPI0714930A2 (pt) * 2006-07-28 2013-05-21 Adlyfe Inc sondas peptÍdicas para fins diagnàsticos e terapÊuticos
WO2008083972A2 (en) * 2007-01-12 2008-07-17 Alicon Ag Method for removing prion protein
WO2009130612A2 (en) 2008-04-25 2009-10-29 University Of Saskatchewan Prion epitopes and methods of use thereof
AU2009243060A1 (en) * 2008-04-30 2009-11-05 Novartis Ag. Assay for pathogenic conformers
US20120009209A1 (en) * 2010-06-10 2012-01-12 The Regents Of The University Of California Enrichment and purification of infectious prion proteins
CN103221823A (zh) * 2010-09-13 2013-07-24 Abbvie公司 高度灵敏的单克隆抗体残留物检测测定法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI90990C (fi) * 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
DE3752345T2 (de) 1986-04-30 2002-08-22 Igen International, Inc. Elektrolumineszente Verbindungen und Zwischenprodukte zur Herstellung
SU1529119A1 (ru) 1987-04-20 1989-12-15 Белорусский научно-исследовательский институт эпидемиологии и микробиологии Способ определени нейровирусов в спинномозговой жидкости
US4806627A (en) * 1987-05-29 1989-02-21 Research Foundation Of Mental Hygiene Inc. Hybrid cell lines producing monoclonal antibodies dircted against scrapie-associated fibril proteins
AU9028791A (en) 1990-10-05 1992-04-28 President And Fellows Of Harvard College Detection and isolation of ligands
WO1992008731A2 (en) 1990-10-30 1992-05-29 La Jolla Cancer Research Foundation T-cadherin adhesion molecule
EP0616613B1 (en) * 1991-12-03 1999-03-17 Proteus Molecular Design Limited Fragments of prion proteins
CA2111573C (en) * 1992-04-17 2002-11-26 Shintaro Suzuki Cadherin materials and methods
US5597725A (en) * 1992-04-17 1997-01-28 Doheny Eye Institute Cadherin-specific antibodies and hybridoma cell lines
US5646250A (en) * 1992-04-17 1997-07-08 Doheny Eye Institute Cadherin polypeptides
WO1993023432A1 (en) 1992-05-15 1993-11-25 New York University Soluble prion polypeptides, and methods for detecting and purifying thereof
US5276059A (en) 1992-07-10 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of diseases associated with amyloid formation
US5798224A (en) 1992-12-29 1998-08-25 Doheny Eye Institute Nucleic acids encoding protocadherin
US5643781A (en) * 1992-12-29 1997-07-01 Doheny Eye Institute DNA encoding protocadherin-42
US5679530A (en) 1995-04-12 1997-10-21 Ludwig Institute For Cancer Research Isolated protein having molecular weight of from about 55 kilodaltons to about 65 kilodaltons (SDS-page) which binds to prion protein
US5948763A (en) 1995-06-07 1999-09-07 New York University Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
EP1416280A3 (en) 1995-09-14 2005-08-10 The Regents of the University of California Antibodies specific for native PrPsc
US5750361A (en) * 1995-11-02 1998-05-12 The Regents Of The University Of California Formation and use of prion protein (PRP) complexes
WO1997043649A1 (en) 1996-05-14 1997-11-20 Winnacker Ernst Ludwig CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrP?sc¿
EP0920630B1 (en) * 1996-05-29 2002-07-31 McGILL UNIVERSITY Prion binding proteins and uses thereof
US5891641A (en) * 1997-02-21 1999-04-06 The Regents Of The University Of California Assay for disease related conformation of a protein
EP0861900A1 (en) 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
DE19741607A1 (de) 1997-09-20 1999-03-25 Prionics Ag Synthetische Polypeptide zur Diagnose und Therapie von Prionerkrankungen
US6165784A (en) 1997-10-14 2000-12-26 The United States Of America As Represented By The Secretary Of Agriculture Antibodies for the detection of prion protein as an indication of transmissible spongiform encephalopathies
KR20010041135A (ko) 1998-02-20 2001-05-15 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 단백질의 다중의 질병 관련된 입체구조의 특이적인스트레인에 대한 분석
US6211149B1 (en) * 1998-08-03 2001-04-03 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors of formation of protease resistant prion protein
GB2348203B (en) * 1998-11-04 2002-06-19 Imp College Innovations Ltd Solube beta-forms of prion proteins, methods of preparation and use
HK1048955A1 (zh) * 1999-06-23 2003-04-25 Idexx Laboratories, Inc. 朊病毒蛋白肽及其应用
CA2376914A1 (en) * 1999-06-29 2001-01-04 Mcgill University Prion protein binding proteins and uses thereof
AU2001251358A1 (en) * 2000-04-05 2001-10-23 V.I. Technologies, Inc. Prion-binding ligands and methods of using same
DE10230141B4 (de) * 2002-07-04 2004-07-15 Priontype Gmbh Verfahren und Kit zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc)
US20040072236A1 (en) 2002-09-27 2004-04-15 Neil Cashman PrPSc -interacting molecules and uses thereof

Similar Documents

Publication Publication Date Title
JP2006507484A5 (enExample)
JP2004538039A5 (enExample)
JP2004506350A5 (enExample)
JP2006503588A5 (enExample)
JP2005526058A5 (enExample)
JP2004171519A5 (enExample)
JP2005509846A5 (enExample)
NO20053133D0 (no) Kjemiske forbindelser.
JP2005533147A5 (enExample)
JP2007520565A5 (enExample)
JP2005527457A5 (enExample)
JP2006511228A5 (enExample)
JP2003160581A5 (enExample)
JP2006512466A5 (enExample)
JP2009520682A5 (enExample)
BR0300119B1 (pt) composiÇço aquosa.
JP2002240244A5 (enExample)
ITMI20030341A1 (it) Sistema per controllare la fabbricazione di una molla.
JP2005515754A5 (enExample)
NO20040665L (no) Produksjon av hydrokarboner.
JP2005518781A5 (enExample)
NO20053151D0 (no) Fremgangsmate for a produsere mikrosystemer.
JP2005061961A5 (enExample)
JP2008514710A5 (enExample)
JP2006500360A5 (enExample)